Emerald Clinical Trials
Singapore, Singapore· Est.
A Singapore‑based global CRO specializing in renal, oncology, and cardiometabolic trials with extensive APAC reach.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
A Singapore‑based global CRO specializing in renal, oncology, and cardiometabolic trials with extensive APAC reach.
RenalOncologyCardiovascularCardiometabolicEarly‑Phase Research
Technology Platform
Provides integrated, end‑to‑end clinical trial services—including regulatory, monitoring, safety, and real‑world evidence—backed by a global investigator network and deep therapeutic expertise.
Opportunities
Expansion of decentralized trial capabilities and real‑world evidence services in the fast‑growing APAC market.
Risk Factors
Intense competition from larger CROs and potential regulatory shifts that could affect trial timelines.
Competitive Landscape
Competes with global CRO leaders such as IQVIA, Covance, and PPD, differentiating through its renal focus and strong APAC operational network.